Your email has been successfully added to our mailing list.

×
0.00125156445556944 0.0257071339173969 0.0313141426783481 0.0337922403003756 0.0438297872340427 -0.016270337922403 0.0364205256570714 0.108886107634543
Stock impact report

CNN values your feedback [CNN]

iBio, Inc. (IBIO) 
NASDAQ:AMEX Investor Relations: ir.ibioinc.com
Company Research Source: CNN
iBio, Inc. is a biotechnology company, which engages in the development and manufacture of biotherapeutics. It focuses on the development of precision antibodies. The company was founded on April 17, 2008 and is headquartered in Bryan, TX. Sector Health Technology Industry Pharmaceuticals: Other Employees Founded Website Key terms IBIO Financials Q earnings, quarter ending Dec 30, 2023 Total revenue n/a n/a Net income - 4.49M Earnings per share Net profit margin n/a n/a Free cash flow - 4.71M Debt-to-equity ratio Key terms IBIO Forecasts 1 analyst rating buy hold sell The only analyst covering IBIO currently rates the stock buy. We're sorry, but this information is temporarily unavailable. IBIO Competitors Key terms Show less Read more
Impact Snapshot
Event Time:
IBIO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for
IBIO alerts

from News Quantified
Opt-in for
IBIO alerts

from News Quantified